SCHEMBL890364

SCHEMBL890364

CCC(c1ccc2cc(OC)ccc2c1)c1cc(S(=O)(=O)O)ccc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 7/20 0.51
AKR1C2 P52895 7/20 0.51
PTGS1 P23219 3/20 0.51
AKR1C1 Q04828 1/20 0.51
ABCB11 O95342 1/20 0.46
PTGS2 P35354 4/20 0.45
TSHR P16473 2/20 0.45
CDC42 P60953 1/20 0.45
RAC1 P63000 1/20 0.45
CYP1A2 P05177 1/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
BCHE P06276 1/20 0.43
TYR P14679 1/20 0.43
ACHE P22303 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C9 P11712 1/20 0.43
CA12 O43570 5/20 0.42
CA1 P00915 5/20 0.42
CA2 P00918 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28564255 0.77 LMNA (0.42) TSHRCYP1A2LMNAMAPTCYP2C9
SCHEMBL1726389 0.76 MEN1 (0.61) PTGS2TSHRCYP1A2LMNA
SCHEMBL4016088 0.74 MEN1 (0.59) PTGS2TSHRCYP1A2LMNA
SCHEMBL3772672 0.74 MEN1 (0.59) PTGS2TSHRCYP1A2LMNA
SCHEMBL2326546 0.73 MEN1 (0.58) PTGS2TSHRCYP1A2LMNA
SCHEMBL9568576 0.72 HTT (0.38) TSHRCYP1A2LMNAMAPTCYP2C9
Hydrochloric Acid SCHEMBL27504393 0.72 MEN1 (0.56) PTGS2TSHRCYP1A2LMNA
SCHEMBL9615906 0.70 HTT (0.43) TSHRLMNAMAPT
SCHEMBL14566923 0.70 AKR1C3 (0.49) AKR1C3AKR1C2ABCB11TSHRCYP2C9
SCHEMBL8586535 0.70 HTT (0.39) TSHRCYP1A2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2860169-B1 Method for obtaining novel derivatives of naphtalene for the in vivo diagnosis of Alzheimer's disease CENTRO DE NEUROCIENCIAS DE CUBA (CU) 2018-08-29 EP disclosed
EP-2860169-A2 Method for obtaining novel derivatives of naphtalene for the in vivo diagnosis of Alzheimer's disease Centro De Neurociencias De Cuba (CU) 2015-04-15 EP disclosed
EP-2436666-A2 METHOD FOR OBTAINING NOVEL DERIVATIVES OF NAPHTALENE FOR THE IN VIVO DIAGNOSIS OF ALZHEIMER 'S DISEASE Centro De Neurociencias De Cuba (CU) 2012-04-04 EP disclosed